Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Benitec Biopharma (BNTC) EPS (Basic) (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed EPS (Basic) for 7 consecutive years, with -$0.84 as the latest value for Q2 2025.

  • Quarterly EPS (Basic) fell 663.64% to -$0.84 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$1.52 through Jun 2025, up 74.79% year-over-year, with the annual reading at -$1.05 for FY2025, 13.93% up from the prior year.
  • EPS (Basic) hit -$0.84 in Q2 2025 for Benitec Biopharma, down from -$0.24 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.11 in Q2 2024 to a low of -$36.27 in Q2 2022.
  • Historically, EPS (Basic) has averaged -$3.51 across 5 years, with a median of -$0.72 in 2021.
  • Biggest five-year swings in EPS (Basic): plummeted 11990.0% in 2022 and later soared 95.85% in 2024.
  • Year by year, EPS (Basic) stood at -$0.59 in 2021, then crashed by 466.1% to -$3.34 in 2022, then rose by 20.96% to -$2.64 in 2023, then soared by 90.15% to -$0.26 in 2024, then crashed by 223.08% to -$0.84 in 2025.
  • Business Quant data shows EPS (Basic) for BNTC at -$0.84 in Q2 2025, -$0.24 in Q1 2025, and -$0.26 in Q4 2024.